Organization
Ruijin Hospital
71 clinical trials
Clinical trial
A Single Center, Randomized Controlled, Open Trial Exploring the Regulatory Effect of Telitacicept on Antibody Titers in Primary Antiphospholipid Syndrome Patients Carrying High-risk Antiphospholipid Antibody ProfilesStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Multicenter Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of EsophageusStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2026-12-31
Clinical trial
Comparing the Efficacy and Safety of Decitabine-Fludarabine-busulfan (Dec-FB4) and Fludarabine-busulfan (FB4) as Conditioning Regimens for AML-MRStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis: A Multi-cohort, Multi-center Clinical Trial (ALTER-G-001)Status: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Clinical Study of Personalized Tumor Vaccines mRNA-0217/S001 and Pembrolizumab in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Evaluation on the Influence of Shenqu Xiaoshi Oral Liquid for the Intestinal Microbiome of Children With Functional DyspepsiaStatus: Recruiting, Estimated PCD: 2023-12-25
Clinical trial
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer With EGFR Mutation and PD-L1 Positive Expression: a Prospective, Open-label, Multicenter, Single-arm Phase II Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2027-01-31
Clinical trial
Using Cryoballoon Ablation as Initial Treatment for Patients With Persistent Atrial Fibrillation Comparing to Anti-arrhythmic DrugsStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Prospective, Single-arm Clinical Study to Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FLU-BU-MEL Conditioning for Myelodysplastic SyndromesStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Multicohort, Single-Centre, Phase II Trial of the Efficacy and Safety of Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid CancerStatus: Not yet recruiting, Estimated PCD: 2024-11-15
Clinical trial
The Effect of Dexmedetomidine on Patients With Chronic Insomnia and Its Influence on Circadian Rhythm:Randomized Clinical Trial, Double BlindStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
The Effect of PERT on Postoperative Complications and Physiological Status in Patients Undergoing PancreaticoduodenectomyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
Efficacy and Safety of Blinatumomab Maintenanceafter Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Acute B-lymphoblastic Leukemia: a Multicenter, Open-label, Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
Phase I Study of High Efficient Killing Cell Therapy for Advanced Non Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Organ Protective Effect of Histamine H1 Receptor Antagonist In Patients With Severe Burns: A Clinical StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
To Investigate the Safety, Tolerability, Efficacy and Pharmacokinetics of T Cell Receptor T Cell Therapy in the Treatment of Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-06-07
Clinical trial
The Effect of Perioperative DEXamethasone on Postoperative Complications After PANcreaticoduodenectomyStatus: Completed, Estimated PCD: 2023-09-14
Clinical trial
A Prospective Phase II Study of PARP Inhibition and Check Point-inhibition Immunotherapy With Concurrent Stereotactic Body Radiotherapy (SBRT) in Patients With Metastatic or Advanced SarcomaStatus: Recruiting, Estimated PCD: 2026-08-30
Clinical trial
A Prospective Phase II Clinical Trial on Pre-operative Immunotherapy and Stereotactic Body Radiotherapy Followed by Metastasectomy in Patients With Pulmonary Resectable Recurrence of OsteosarcomaStatus: Recruiting, Estimated PCD: 2026-09-15
Clinical trial
(CHANT)A Prospective, Multicenter, Non-interventionistic Real-world Study of Duvelisib Capsules in the Treatment of Non-Hodgkin's Lymphoma (NHL).Status: Not yet recruiting, Estimated PCD: 2027-11-30
Clinical trial
Nimotuzumab Plus Adjuvant Chemotherapy vs Adjuvant Chemotherapy Alone for Resectable Pancreatic Cancer: a Propensity Score Matching AnalysisStatus: Completed, Estimated PCD: 2022-07-31
Clinical trial
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2026-10-01
Clinical trial
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer vs Cross Therapy.Status: Not yet recruiting, Estimated PCD: 2028-03-01
Clinical trial
Improving Microcirculation and Microvascular Leakage in Sepsis Patients: A Comprehensive Clinical Study of Shenfu InjectionStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Resectable Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma: A Multicenter, Randomized Phase II-III TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
A Single-Arm Clinical Study of CD19 CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic FactorsStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma: a Phase Ⅱ Single Arm Prospective StudyStatus: Recruiting, Estimated PCD: 2026-11-01
Clinical trial
A Phase II Study of Gemcitabine-docetaxel Chemotherapy With Anti-angiogenic Therapy for Pulmonary Resectable Metastases of OsteosarcomaStatus: Active (not recruiting), Estimated PCD: 2023-11-15
Clinical trial
Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System InvolvementStatus: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
A Study on the Treatment Strategy of Neovascular Glaucoma Secondary to Proliferative Diabetic RetinopathyStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST Study)Status: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Biomarker Driven, Open Label, Phase II Study of VEGFR2 Inhibitor Apatinib in Patients With Recurrent or Refractory Advanced Bone and Soft Tissue SarcomaStatus: Recruiting, Estimated PCD: 2024-02-25
Clinical trial
Clinical Study of Personalized Tumor Vaccines mRNA-0217/S001 and Pabolizumab in Patients With Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-11-30
Clinical trial
Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon CancerStatus: Not yet recruiting, Estimated PCD: 2026-02-28
Clinical trial
Selinexor Combined With R-GDP Regimen for TP53-altered Relapsed/Refractory Diffuse Large B-cell Lymphoma: a Single Arm, Single Center, Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2024-04-30
Clinical trial
Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed Primary Central Nervous System Large B-Cell Lymphoma Patients Intolerant to Haematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Single-arm Prospective Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell LymphomaStatus: Recruiting, Estimated PCD: 2027-05-31
Clinical trial
A Study to Evaluate the Efficacy and Safety of Genotype-guided Targeted Agents in Combination With POLA-RCHP VERSUS POLA-RCHP in Patients With Previously Untreated Diffuse Large B-cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2027-12-31
Clinical trial
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell LymphomaStatus: Recruiting, Estimated PCD: 2027-11-01
Clinical trial
An Evaluation of LY007 Cell Injection for Recurrent/Refractory CD20 Was Positive Tolerability, Safety, and Efficacy of B-cell Non-Hodgkin Lymphoma in Open, Single-arm Stage I Clinical ResearchStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
Effect of Propofol in Combination With Oxycodone on Anxiety State in Painless Abortion - A Multicenter Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-06-30
Clinical trial
Guidance-04：T-cell Lymphoma Series：A Genotype-guided Therapy in Newly Diagnosed Patients With Peripheral T-cell Lymphoma （THEORY Study）Status: Recruiting, Estimated PCD: 2026-07-15
Clinical trial
Evaluation of the Efficacy of Different Duration of a Proton Pump Inhibitor in the Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass GraftingStatus: Active (not recruiting), Estimated PCD: 2023-12-30
Clinical trial
A Phase II Study of BTKi+Radiotherapy±Chemotherapy Bridging Before Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T) in Combination With BTKi±PD-1 Inhibitor Maintenance Therapy for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (r/r B-NHL)Status: Recruiting, Estimated PCD: 2024-05-20
Clinical trial
A Real-world Study of the Efficacy and Safety of Obinutuzumab-based Therapy for Previously Untreated Follicular LymphomaStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Effect of Nicorandil, Diltiazem or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts - A Pilot Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-02-02
Clinical trial
The Safety and Effectiveness of Four Courses of R-CHOP Plus Four Courses of Rituximab Versus Six Courses of R-CHOP Plus Two Courses of Rituximab in the Treatment of Naive, Low-risk, Non-mass Diffuse Large B-cell Lymphoma: a Multi-center, Prospective, Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2025-09-15
Clinical trial
Efficacy and Safety of Venetoclax Combined With BEAM (Carmustine, Etoposide Cytarabine and Melphalan) Pretreatment in Autologous Stem Cell Transplantation for Diffuse Large B-cell Lymphoma: a Single-center, Randomized Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2024-11-30
Clinical trial
Real World Study of Linperlisib for Lymphoma Treatment: Multicenter, Non-interventional and Observational Real-world StudyStatus: Not yet recruiting, Estimated PCD: 2027-06-01
Clinical trial
The Efficacy and Safety of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Versus Rituximab Combined With Low-dose CHOP (R-miniCHOP) in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years: A Multicenter, Prospective, Randomized, Open-label, Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-25
Clinical trial
A Single-arm Prospective Trial of Axicabtagene Ciloleucel (Axi-cel) Retreatment in Relapsed/Refractory Large B-cell LymphomaStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety of Huaier Granule in Combination With Nilaparil in First-line Maintenance Therapy in Postoperative Patients With Stage III/IV BRCA Wild-type Ovarian Cancer: a Single-center Prospective, Single-arm StudyStatus: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Study Comparing the Efficacy and Safety of Genotype-guided R-CHOP-X Versus R-CHOP in Patients With Diffuse Large B-Cell LymphomaStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
The Safety and Feasibility of Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Locally Advanced Resectable Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety of Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer: a Single-center Prospective Single-arm StudyStatus: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Real-world Study: Efficacy and Safety of Selinexor-based Regimens for Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2024-10-10
Clinical trial
Sacubitril/Valsartan for Dialysis Patients With CKD5 Stage Complicated With Hypertension- A Prospective, Randomized, Controlled Multicenter StudyStatus: Completed, Estimated PCD: 2023-03-01
Clinical trial
A Prospective, Multicenter, and Exploratory Study of Mitoxantrone Liposomes, Cytarabine and G-CSF Combined With Vineclavone in the Treatment ofRecurrent Adult AML and MDS-EB-2/Elder AMLStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Prospective, Randomized, Blank Control, Multicenter Study to Evaluate the Efficacy and Safety of Alanine Aminotransferase（TMF）in the Treatment of Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.Status: Active (not recruiting), Estimated PCD: 2024-06-15
Clinical trial
A Randomized, Double-blind, Multi-center Clinical Study of the Efficacy of Idebenone in the Treatment of Primary Rapid Eye Movement Sleep Behavior Disorder Into SynucleinopathiesStatus: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Effect of Albumin Infusion in Patients With Decompensated Cirrhosis Hospitalized for Treatment of Complications of Liver DiseaseStatus: Not yet recruiting, Estimated PCD: 2023-12-31
Clinical trial
The Efficacy and Safety of Targeted Drug in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in the Treatment of Newly Diagnosed Peripheral T-Cell LymphomaStatus: Active (not recruiting), Estimated PCD: 2023-04-20
Clinical trial
Toripalimab Combined With Definitive Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma PatientsStatus: Recruiting, Estimated PCD: 2028-12-31
Clinical trial
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid LeukemiaStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk Core-binding-factor Acute Myeloid LeukemiaStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
Development and Validation of the ChemoResist Signature Precisely Predictive of Chemotherapy Sensitivity in Resected Pancreatic Ductal AdenocarcinomaStatus: Completed, Estimated PCD: 2020-03-16
Clinical trial
A Prospective, Randomized Controlled Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence Patients Receiving Glucocorticoid Maintenance Therapy/Glucocorticoid Combined With MMF Maintenance TherapyStatus: Recruiting, Estimated PCD: 2027-03-31
Clinical trial
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility StudyStatus: Recruiting, Estimated PCD: 2025-05-31